Skip to main content
search
All Posts By

Ben Kemp

HighlightsHighlights Archive

Value-based procurement (VBP) assessment methodology set for June release

The Department of Health and Social Care (DHSC) is preparing to introduce its new value-based procurement (VBP) framework in June, remaining on schedule for rollout. Senior figures are set to promote the initiative at major industry gatherings during that month. David Lawson, who leads the DHSC’s Medical Technology and Innovation Directorate, will outline the methodology at Med-Tech Expo in Birmingham…
Ben Kemp
April 28, 2026
Membership NewsMembership News Archive

Helen pens NHS innovation article for Chamber UK journal

BIVDA Chief Executive Helen Dent has had her article, 'Pass the Baton: Why NHS Innovation Stalls at the Finish Line', published in Chamber UK journal, read by parliamentarians across both Houses. In the article, Helen observed that, despite widespread agreement across industry, the NHS and government on what needs to change, progress remains limited. She noted that while experts have…
Ben Kemp
April 28, 2026
Membership NewsMembership News Archive

BIVDA Webinar: From Snapshot to Stream: How Continuous Health Data May Reshape Diagnostics

Date and time: Tuesday 12th May 2026 at 2pm - 3pm Traditional IVDs provide high-quality diagnostic snapshots. However, healthcare delivery is increasingly moving toward continuous, remote, and prevention-driven models. This session explores how longitudinal wearable data and digital biomarkers may complement in vitro diagnostics, and what this shift means for product design, clinical evidence, regulatory pathways, and NHS integration. This…
Ben Kemp
April 27, 2026
Membership NewsMembership News Archive

Helen meets with Health Committee Chair Layla Moran MP

Last week, BIVDA Chief Executive Helen Dent met with Chair of the Health and Social Care Committee Layla Moran MP during a roundtable on the future of UK health policy. Despite the Government identifying our sector as critical to economic growth and global biosecurity, Helen highlighted that companies continue to face significant barriers to NHS adoption – driven by short-term…
Ben Kemp
April 27, 2026
Membership NewsMembership News Archive

BIVDA Webinar: What could quantum sensing mean for the future of IVDs?

BIVDA members are invited to join experts from the Q-BIOMED hub for an interactive session on Tuesday 16th June at 1pm - 2pm on how quantum sensing technologies could reshape the way disease is detected, measured, and understood across clinical pathways. This webinar will unpack the science behind these emerging approaches in an accessible way, asking questions such as: how…
Ben Kemp
April 27, 2026
HighlightsHighlights Archive

NIHR launches global programme to tackle antimicrobial resistance (AMR)

The National Institute for Health and Care Research (NIHR) has announced a new global health funding opportunity to combat AMR. The initiative, funded by the Department of Health and Social Care (DHSC), will allow researchers to apply for between £500,000 and £5 million to transform their promising research into solutions which can be embedded into daily clinical practice. The programme…
Ben Kemp
April 24, 2026
Membership NewsMembership News Archive

BIVDA welcomes new members: Molbio Diagnostics, OPD (Oxford Product Design) and Imprinted Diagnostics

This week, we are pleased to welcome three new members to our community: Molbio Diagnostics, OPD (Oxford Product Design) and Imprinted Diagnostics. Imprinted Diagnostics have created a portable blood test for high sensitivity troponin I for use in a pre-hospital environment, with a mission to deliver fast, accurate diagnosis anywhere; saving lives and closing the healthcare gap in underserved regions.…
Ben Kemp
April 24, 2026
Membership NewsMembership News ArchiveProcurement Working PartyProcurement Working Party Archive

NHS Supply Chain Market Engagement Notice: In-Vitro Diagnostics, Point of Care Testing & Pathology Services

NHS Supply Chain intends to launch a National Framework Agreement for the provision of In-Vitro Diagnostic Devices, Point of Care Testing Products & Related Pathology Services, this will include: - Pathology Managed Services - Reagent Rental Agreements - Pathology Maintenance Services - Pathology Software - Pathology Outsourced Services (Referral Testing Services) - Core Laboratory Equipment, Instruments & Consumables, to cover…
Ben Kemp
April 15, 2026
Close Menu